Replies to post #1792 on CryoPort Inc (CYRX)

[tigertrader]

Cryoport and Long Cryoport: Differing opinions... they keep things interesting, at the very least. Only time will tell who is correct, and who is incorrect.
IMO, CYRX is at best, dead money, and will remain so for quite a while. By the time it works, IF it ever works, you'll be able use the profits to buy batteries for your hearing aids. And at worst, it's toast.
BTW: IF and WHEN, the economy and the markets, turn around, I'd much rather buy GE at $6-$8 than buy CYRX at 0.42 - 0.20, even if "GE's growth days are behind them".

[jwinston2]

The problem is many of those companies that do vaccine shipments are not immune to the problems facing the economy. I am not suggesting they will stop research or products but the question should be asked will they spend the time to switch methods? In this environment, even if Cryoport in theory can save them a lot of money, they may very well not switch.

From my memory the biggest company named by Cryoport has been Quest, which is not a drug manufacturer, below is a list of some of the larger drug companies, all who seem to be affected by the current market. Hopefully Tiger is wrong but it is hard to ignore his point, very few companies prosper in the type of economy we are currently in.

Eli Lilly & Co. (LLY)
Pfizer (PFE)
Novartis AG (NVS)
Merck (MRK)
Johnson & Jonshon (JJ)
GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)
AstraZeneca plc (AZN)
Abbott Laboratories (ABT)
Bristol-Myers Squibb Co. (BMY)